Glucose monitoring after Acute Myocardial infarct in people with diabetes is a Dexcom funded study that is investigating whether the use of continuous glucose monitors (Dexcom ONE model) in people with type 2 diabetes facilitates time in glycaemic range in the 6 months after an acute myocardial infarction. As an exploratory outcome it will investigate whether time in glycaemic range is associated with changes in mortality and major adverse cardiac events in the 6 months after acute myocardial infarct.
Adults aged >18 years
Known or newly diagnosed type 2 diabetes
Taking one or more oral hypoglycaemic agent, GLP1 receptor analogue and/or insulin
Admitted to Hammersmith Hospital cardiology inpatient services with ACS
HbA1c <48mmol/mol
People who have previously had bariatric surgery
People taking hydroxyurea
People who undergo haemodialysis or peritoneal dialysis